A gene ther­a­py leader stum­bles, Medicx­i's splashy 10-in-1 start­up play, a rad­i­cal HIV cure gets its shot​, and ...

5 years ago
Weekly

Af­ter cross­ing t's, dot­ting i's, Im­muno­core nails down break­through ther­a­py des­ig­na­tion for lead TCR ther­a­py

5 years ago
FDA+

In­cyte scores speedy FDA re­view for JAK cream in atopic der­mati­tis; Lil­ly backs $90M raise for Re­gor

5 years ago
News Briefing

Jim Wilson's team hands Pre­ci­sion Bio a big proxy win for its PC­SK9 gene edit­ing tech with 3-year mon­key da­ta

5 years ago
Cell/Gene Tx

Ore­gon's Cas­cade Chem­istry looks to boost its Amer­i­can-made API pro­duc­tion with $14M in­vest­ment

5 years ago
Manufacturing

Ab­b­Vie puts an end to Botox trade se­crets suit, im­pos­es roy­al­ty, li­cense deal on com­peti­tor Evo­lus

5 years ago
Pharma

Bio­phar­ma ex­ecs rou­tine­ly shun re­veal­ing the hard truth when it comes to RTFs. And some peo­ple at the FDA think ...

5 years ago
Bioregnum
FDA+

Astel­las scores a pair of tri­al wins for menopausal hot flash med, rais­ing the pitch of loom­ing Bay­er stand­off

5 years ago
R&D

Old-hat in­vestors Al­ta Part­ners snag $275M for their newest next-gen fund, more than dou­ble the first it­er­a­tion from ...

5 years ago
Financing

The SPAC boom con­tin­ues to churn out heavy cap­i­tal, as Fore­site prices its $175M blank check com­pa­ny and 2 oth­ers ...

5 years ago
Financing

Covid-19 roundup: Pfiz­er/BioN­Tech say vac­cines can be stored short term at nor­mal freez­er temps; Fau­ci warns of ...

5 years ago
Coronavirus

Hen­ry Skin­ner buys time in the fight against an­timi­cro­bial re­sis­tance; Ver­tex's Michael Pari­ni be­comes pres­i­dent and ...

5 years ago
Peer Review

No­vavax promis­es more vac­cines to CO­V­AX for low- and mid­dle-in­come na­tions, bring­ing to­tal com­mit­ment to 1.1B shots

5 years ago
Coronavirus

Covid-19 Man­u­fac­tur­ing Roundup: Ther­mo Fish­er plant ramps up As­traZeneca vac­cine pro­duc­tion; No­vavax ex­pands Ko­re­an ...

5 years ago
Coronavirus
Manufacturing

End­points Man­u­fac­tur­ing: 5 Ques­tions with Ho­mol­o­gy Med­i­cines

5 years ago
People
Manufacturing

Mallinck­rodt be­comes the lat­est vic­tim of the FDA's pan­dem­ic-re­lat­ed de­lays as it push­es off ap­pli­ca­tion for skin ...

5 years ago
Pharma
FDA+

Is­raeli API mak­er Wave­length buys up ma­jor­i­ty stake in In­di­an firm mak­ing drug start­ing ma­te­ri­als and in­ter­me­di­ates

5 years ago
Outsourcing
Manufacturing

Proven­tion Bio inks Chi­na deal for au­toim­mune pro­gram; Ky­owa Kirin re­leas­es pos­i­tive topline da­ta in atopic ...

5 years ago
News Briefing

Amid the 'su­per­bug' cri­sis, a Big Phar­ma-backed fund scores a mea­ger raise for an­tibi­otics R&D. Is $140M near­ly ...

5 years ago
Financing

Roy­al­ty Phar­ma gets more com­pe­ti­tion as a pri­vate eq­ui­ty firm launch­es $725M roy­al­ty-buy­ing fund

5 years ago
Financing

Im­mu­nic's lead drug fails to im­press in 2 sep­a­rate tri­als — and it's blam­ing some of its woes on the pan­dem­ic

5 years ago
R&D

5 years lat­er, CAR-T pi­o­neer Kym­ri­ah of­fers jaw-drop­ping ev­i­dence of durable re­mis­sions — even as it still proves a ...

5 years ago
R&D
Pharma

End­points Man­u­fac­tur­ing: Charles Riv­er makes a splash for cell and gene ther­a­py spe­cial­ist; 5 ques­tions with Ho­mol­o­gy ...

5 years ago
Manufacturing

Cen­tu­ry Ther­a­peu­tics boosts iP­SC man­u­fac­tur­ing space in New Jer­sey as part of com­pa­ny wide ex­pan­sion

5 years ago
Cell/Gene Tx
Manufacturing
First page Previous page 741742743744745746747 Next page Last page
A service from the Financial Times